CO53 Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.127
https://www.valueinhealthjournal.com/article/S1098-3015(23)00227-9/fulltext
Title :
CO53 Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00227-9&doi=10.1016/j.jval.2023.03.127
First page :
Section Title :
Open access? :
No
Section Order :
10737